Chewy, Inc.
20.75USD
-2.5200 (-10.83%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.36▼ | $0.41 | 0 | 1 |
| Next quarter | $0.38▼ | $0.42 | 0 | 1 |
| Current year | $1.52▼ | $1.63 | 0 | 1 |
| Next year | $1.83▼ | $1.96 | 0 | 2 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-04-30 | $0.43 | $0.43 | +0.00 (+0.8%) |
| 2026-01-31 | $0.28 | $0.27 | -0.01 (-3.1%) |
| 2025-10-31 | $0.3 | $0.32 | +0.02 (+5.4%) |
| 2025-07-31 | $0.33 | $0.33 | -0.00 (-0.5%) |
325 ratings from 37 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Raymond James | Maintained | Outperform | $25 $28 | Sep 4, 2026 |
| Mizuho | Maintained | Outperform | $40 $32 | Sep 4, 2026 |
| Morgan Stanley | Maintained | Overweight | $42 $37 | Aug 26, 2026 |
| RBC Capital | Reiterated | Outperform | $34 | Aug 26, 2026 |
| Rosenblatt | Initiated | Neutral | $25 | Aug 20, 2026 |
| Goldman Sachs | Maintained | Buy | $46 $34 | Jun 12, 2026 |
| UBS | Maintained | Neutral | $32 $24 | Jun 11, 2026 |
| JP Morgan | Maintained | Overweight | $35 $29 | Jun 11, 2026 |
| RBC Capital | Maintained | Outperform | $47 $34 | Jun 11, 2026 |
| TD Cowen | Maintained | Buy | $42 $34 | Jun 11, 2026 |
| Citizens | Maintained | Market Outperform | $45 $28 | Jun 11, 2026 |
| Barclays | Maintained | Overweight | $40 $36 | Jun 11, 2026 |
| Baird | Maintained | Outperform | $40 $30 | Jun 11, 2026 |
| Needham | Reiterated | Hold | — | Jun 11, 2026 |
| Mizuho | Maintained | Outperform | $50 $40 | Jun 3, 2026 |
| JP Morgan | Maintained | Overweight | $40 $35 | Jun 2, 2026 |
| Morgan Stanley | Maintained | Overweight | $49 $43 | May 26, 2026 |
| Barclays | Maintained | Overweight | $48 $40 | May 26, 2026 |
| Citigroup | Maintained | Buy | $40 $37 | May 12, 2026 |
| Guggenheim | Reiterated | Buy | $45 | Apr 27, 2026 |
| Guggenheim | Reiterated | Buy | $45 | Apr 13, 2026 |
| Morgan Stanley | Maintained | Overweight | $50 $49 | Mar 31, 2026 |
| RBC Capital | Maintained | Outperform | $43 $47 | Mar 30, 2026 |
| Citigroup | Maintained | Buy | $42 $40 | Mar 27, 2026 |
| JP Morgan | Maintained | Overweight | $46 $40 | Mar 26, 2026 |
88 filings from 17 insiders · 14 buy / 4 sell over 6m
Officers and directors of CHWY, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Hu Da-WaiOfficer, General Counsel & Secretary | Tax | 445 | $23.80 | $11k | Sep 1, 2026 |
| Billings William G.Officer, Chief Accounting Officer | Tax | 625 | $23.80 | $15k | Sep 1, 2026 |
| Deppe Christopher S.Officer, Chief Financial Officer | Tax | 1.5k | $23.80 | $37k | Sep 1, 2026 |
| Singh SumitDirector; Officer, Chief Executive Officer | Taxindirect | 1.3k | $23.80 | $30k | Sep 1, 2026 |
| Singh SumitDirector; Officer, Chief Executive Officer | Tax | 7.6k | $23.80 | $180k | Sep 1, 2026 |
| SINGH SUMITChief Executive Officer | Sell | 49.5k | $23.01 | $1.14M | Aug 3, 2026 |
| DICKSON KRISTINEDirector | Grant | 10.7k | — | — | Jul 9, 2026 |
| GOLDHABER NATHANIELDirector | Grant | 10.7k | — | — | Jul 9, 2026 |
| NELSON JAMES LARRYDirector | Grant | 10.7k | — | — | Jul 9, 2026 |
| ELLINGER DEBORAH G.Director | Grant | 10.7k | — | — | Jul 9, 2026 |
| STAR JAMES A.Director | Grant | 10.7k | — | — | Jul 9, 2026 |
| NESBITT MARTIN HDirector | Grant | 10.7k | — | — | Jul 9, 2026 |
| HU DA-WAIGeneral Counsel | Sell | 4.2k | $19.48 | $82k | Jun 29, 2026 |
| SINGH SUMITChief Executive Officer | Sell | 87.5k | $25.60 | $2.24M | May 4, 2026 |
| SINGH SUMITChief Executive Officer | Grant | 560.3k | — | — | Apr 8, 2026 |
| BILLINGS WILLIAM G.Officer | Grant | 32.6k | — | — | Apr 8, 2026 |
| DEPPE CHRISTOPHER S.Chief Financial Officer | Grant | 423.7k | — | — | Apr 8, 2026 |
| HU DA-WAIGeneral Counsel | Grant | 37.5k | — | — | Apr 8, 2026 |
| HU DA-WAIGeneral Counsel | Sell | 8.1k | $26.91 | $219k | Apr 1, 2026 |
| SINGH SUMITChief Executive Officer | Grant | 573.9k | — | — | Mar 25, 2026 |
No analyst notes on CHWY yet.
Analyst Ratings
22 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 8 | 12 | 6 | 0 | 0 | Buy1.92 |
| 1 mo ago | 8 | 12 | 6 | 0 | 0 | Buy1.92 |
| 2 mo ago | 8 | 12 | 5 | 0 | 0 | Buy1.88 |
| 3 mo ago | 8 | 12 | 5 | 0 | 0 | Buy1.88 |